Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christy Shaffer | M | 66 |
Trefoil Therapeutics, Inc.
 Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | - |
| Benjamin McGraw | M | 75 |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | 7 years |
| Ben McGraw | M | - |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | - |
| Stella M. Robertson | M | - |
Trefoil Therapeutics, Inc.
Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 4 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Eveleth
- Personal Network
